Influence of G protein type on agonist efficacy

Molecular Pharmacology

Volumn 56, Issue 3, 1999, Pages 651-656

  Yang, Qing ^a,b   Lanier, Stephen M ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 METHOXY 1,4 BENZODIOXAN 2 YL) 2 IMIDAZOLINE; ADRENALIN; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRIMONIDINE; CLONIDINE; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); OXYMETAZOLINE; PERTUSSIS TOXIN; SULFUR 35;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG POTENTIATION; DRUG RECEPTOR BINDING; FIBROBLAST; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0032819108     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.56.3.651     Document Type: Article

References (31)

1. Ariëns EJ (1954) Affinity and intrinsic activity in the theory of competitive inhibition. Arch Int Pharmacodyn Ther 99:32-49.
2. Bahia DS, Wise A, Fanelli F, Lee M, Rees S and Milligan G (1998) Hydrophobicity of residue351 of the G protein Gil alpha determines the extent of activation by the alpha 2A-adrenoceptor. Biochemistry 37:11556-11562.
3. Berg K, Maayani AS, Goldfarb J, Scaramellini C, Leff P and Clarke WP (1998) Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: Evidence for agonist-directed trafficking of receptor stimulus. Mol Pharmacol 64:94-104.
4. Black J (1989) Drugs from emasculated hormones: The principle of syntopic antagonism. Science (Wash DC) 245:486-493.
5. Bonhaus DW, Chang LK, Kwan J and Martin GR (1998) Dual activation and inhibition of adenylyl cyclase by cannabinoid receptor agonists: Evidence for agonist-specific trafficking of intracellular responses. J Pharmacol Exp Ther 287: 884-888.
6. 35S]GTPγS agonist-induced decreases in GDP affinity. J Biol Chem 273:16865-16873.
7. Carty DJ, Padrell E, Codina J and Birnbaumer L, Hildebrandt JD and Iyengar R (1990) Distinct guanine nucleotide binding and release properties of the three Gi proteins. J Biol Chem 266:6268-6273.
8. Cismowski MJ, Takesono A, Ma C, Lizano JS, Xie X, Fuernkranz H, Lanier SM and Duzic E (1999) Functional genomics in the yeast Saccharomyces cerevisia: Cloning of mammalian non-receptor modulators of G-protein signalling pathways. Nature Biotechnology, in press.
9. 2C- adrenergic receptor to the guanine nucleotide binding protein, Go. J Biol Chem 267:9852-9857.
10. 2-adrenergic receptor subtypes to distinct G-proteins. J Biol Chem 267:9844-9851.
11. S Mol Pharmacol 45: 696-702.
12. Ferguson KM, Higashijima T, Smigel MD and Gilman AG (1986) The influence of bound GDP on the kinetics of guanine nucleotide binding to G proteins. J Biol Chem 261:7393-7399.
13. 2-adrenergic and muscarinic receptors in pheochromocytoma (PC-12) cells. Am J Physiol 260:C1282-C1289.
14. Hoyer D and Boddeke HW (1993) Partial agonists, full agonists, antagonists: Dilemmas of definition. Trends Pharmacol Sci 14:270-275.
15. iα1. J Biol Chem 268:19851-19857.
16. Kenakin T (1995) Agonist-receptor efficacy II: Agonist trafficking of receptor signals. Trends Pharmacol Sci 16:232-238.
17. Kenakin T (1997) Differences between natural and recombinant G protein-coupled receptor systems with varying receptor/G protein stoichiometry. Trends Pharmacol Sci 18:456-464.
18. Kenakin TP (1984) The relative contribution of affinity and efficacy to agonist activity: Organ selectivity of noradrenaline and oxymetazoline with reference to the classification of drug receptors. Br J Pharmacol 81:131-141.
19. Kenakin TP and Morgan PH (1989) Theoretical effects of single and multiple transducer receptor coupling proteins on estimates of the relative potency of agonists. Mol Pharmacol 36:214-222.
20. 1 adenosine receptor with receptor/G protein complexes in rat brain membranes. Mol Pharmacol 49:915-926.
21. McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, Solari R, Lee MG and Foord SM (1998) RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature (Lond) 393:333-339.
22. 2-adrenoceptor activation in guinea-pig submucous plexus neurones. J Physiol (Lond) 358:17-33.
23. Perez DM, Hwa J, Gaivin R, Mathur M, Brown F and Graham RM (1996) Constitutive activation of a single effector pathway: evidence for multiple activation states of a G protein-coupled receptor. Mol Pharmacol 49:112-122.
24. Sato M, Kataoka R, Dingus J, Wilcox M, Hildebrandt JD and Lanier SM (1995) Factors determining the specificity of signal transduction by G-protein coupled receptors. IV. Regulation of signal transfer from receptor to G-protein. J Biol Chem 270:15269-15276.
25. Sato M, Ribas C, Hildebrandt JD and Lanier SM (1996) Identification of a G-protein activator in the neuroblastoma-glioma cell hybrid NG108-15. J Biol Chem 271: 30052-30060.
26. Selley DE, Sim LJ, Xiao R, Liu Q and Childers SR (1997) μ-Opioid receptor-stimulated guanosine-5′-O-(γ-thio)-triphosphate binding in rat thalamus and cultured cell lines: Signal transduction mechanisms underlying agonist efficacy. Mol Pharmacol 51:87-96.
27. 2-adrenergic receptors. Biochim Biophys Acta 714:389-394.
28. Surprenant A, Shen KZ, North RA and Tatsumi H (1990) Inhibition of calcium currents by noradrenaline, somatostatin and opioids in guinea-pig submucosal neurones. J Physiol (Lond) 431:585-608.
29. Trombley PQ (1992) Norepinephrine inhibits calcium currents and EPSPs via a G-protein-coupled mechanism in olfactory bulb neurons. J Neurosci 12:3992-3998.
30. Watson N, Linder ME, Druey KM, Kehrl JH and Blumer KJ (1996) RGS family members: GTPase-activating proteins for heterotrimeric G-protein alpha-subunite. Nature (Lond) 383:172-175.
31. Weiss JM, Morgan PH, Lutz MW and Kenakin TP (1996) The cubic ternary complex receptor-occupancy model. J Theor Biol 181:381-397.